World Biopsy Devices Market - Opportunities and Forecasts, 2014 - 2022
- ALL557346
- 158 Pages
- May 2016
- Medical Devices
Biopsy is the surgical removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissue. Biopsy procedures can be performed for almost any organ with the help of a specific biopsy device. Conventional biopsy devices can be complemented with advanced imaging technologies such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others to perform a biopsy procedure with accuracy and minimal invasiveness. These integrated procedures are important to perform biopsies in critical areas of the body such as the lungs, liver, and kidney.
Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements have been stimulating the growth of the biopsy devices market. Moreover, increase in awareness for the diagnosis of chronic diseases such as breast cancer and lung cancer is also increasing the demand for integrated biopsy technologies such as MRI-guided biopsy. On the contrary, the use of advanced biopsy devices in developing countries is still restricted due to high cost, unawareness for the diagnosis of chronic diseases, and lack of technical expertise. However, companies are now concentrating on developing cost-effective biopsy devices, which would decrease the overall cost of biopsy procedures.
The report segments the world biopsy devices market by device type, application, biopsy procedures, imaging technologies, end users, and geography. The types of devices profiled in this report include breast biopsy devices, gastrointestinal (GI) biopsy devices, soft tissue biopsy devices, bronchial biopsy devices, gynaecological biopsy devices, robotic biopsy devices, and other devices. Based on application, the report is segmented into breast biopsy, gastrointestinal (GI) biopsy, prostate, liver, lung, kidney, gynaecological, and others. End users for the biopsy devices market comprise hospitals and diagnostic centers. Geographically, the world biopsy devices market is segmented across North America, Europe, Asia-Pacific, and LAMEA.
Product launches was the most preferred strategy followed by collaborations & geographic expansion for market capitalization. The report provides a comprehensive analysis of the leading companies operating in the world biopsy devices market. The key companies profiled in the report are C.R. Bard, Inc., Leica Biosystems, Hologic, Inc., Becton, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Mauna Kea Technologies, Cook Medical, Inc., Medtronic, Argon Medical Devices, Inc, Intact Medical Corp., and others.
KEY BENEFITS FOR STAKEHOLDERS:
- This report provides an extensive analysis of the current and emerging trends and dynamics in the world biopsy devices market.
- The report provides a detailed analysis of the current market and estimations from 2014 to 2022, which would enable the stakeholders to capitalize on the prevailing opportunities.
- The biopsy devices market scenario is comprehensively analyzed in accordance to key geographical regions.
- The key players are profiled in the report, and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
- Competitive intelligence highlights the business practices followed by leading market players across geographies.
- SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
BIOPSY DEVICES MARKET KEY SEGMENTS:
By Device Type
- Breast biopsy devices
- Gastrointestinal (GI) biopsy devices
- Soft tissue biopsy devices
- Bronchial biopsy devices
- Gynaecological biopsy devices
- Robotic biopsy devices
- Other devices (brushes, punches, and curettes)
By Application
- Breast biopsy
- Gastrointestinal (GI) biopsy
- Prostate
- Liver
- Lung
- Kidney
- Gynaecological
- Others (thyroid, pancreas, and gall bladder)
By Imaging Technology
- CT scan
- Stereotactic-guided biopsy
- Ultrasound-guided biopsy
- MRI-guided biopsy
- Others (positron emission tomography, X-ray, and sonography)
By End User
- Diagnostic centers
- Hospitals
By Geography
- North America
- Europe
- Asia-Pacific
- LAMEA
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2025
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 BIOPSY DEVICE MARKET OVERVIEW
3.1 Market definition and scope
3.2 Market Dynamics
3.2.1 Top impacting factors
3.2.2 Drivers
3.2.3 Restrains
3.2.4 Top winning strategies
3.3 Porters Five Forces analysis
3.3.1 Fewer suppliers lead to higher bargaining power of suppliers
3.3.2 Higher concentration of buyers leads to low bargaining power
3.3.3 High threat of substitutes due to presence of minimal invasive diagnostic procedures
3.3.4 Low threat of new entrants due to high capital investment
3.3.5 Moderate competitive rivalry
3.4 Value chain analysis
3.4.1 Research and product development
3.4.2 Product testing
3.4.3 Manufacturing
3.4.4 End users
3.5 Regulatory norms
3.5.1 Regulatory issues of gastroenterology and urology biopsy devices in North America
3.5.2 Regulatory Scenario for breast biopsy in European Union
3.6 Reimbursement scenario
3.6.1 Reimbursement for Breast Cancer Screening in the U.S.
3.6.2 Reimbursement for Breast Reconstruction or Prosthesis
3.7 Patent analysis
3.7.1 The U.S.: Patent analysis, by market participants
3.7.2 Europe: Patent analysis, by market participant
3.7.3 Japan: Patent analysis, by market participants
CHAPTER 4 MARKET BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Breast biopsy devices
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Types of breast biopsy devices
4.2.4.1 VacuumAssisted Biopsy (VAB) devices
4.2.4.1.1 Market size and forecast
4.2.4.2 Core Needle Biopsy (CNB)
4.2.4.2.1 Market size and forecast
4.2.4.3 Fine Needle Aspiration Biopsy
4.2.4.3.1 Market size and forecast
4.4 Gastro Intestinal biopsy devices
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.5 Soft tissue biopsy devices
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.6 Bronchial biopsy devices
4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.7 Gynaecological Biopsy Devices
4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast
4.8 Robotic Guidance Systems
4.8.1 Key market trends
4.8.2 Key growth factors and opportunities
4.8.3 Market size and forecast
4.9 Others
4.9.1 Key market trends
4.9.2 Key growth factors and opportunities
4.9.3 Market size and forecast
CHAPTER 5 MARKET BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Breast Biopsy
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Gastroenterology Biopsy
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Prostate Biopsy
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.5 Liver biopsy
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.6 Lung biopsy
5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.7 Kidney Biopsy
5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast
5.8 Gynaecological Biopsy
5.8.1 Key market trends
5.8.2 Key growth factors and opportunities
5.8.3 Market size and forecast
5.9 Others
5.9.1 Market size and forecast
CHAPTER 6 MARKET BY IMAGE GUIDED TECHNOLOGY
6.1 Overview
6.1.1 Market size and forecast
6.2 MRIguided biopsy
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 StereotacticGuided Breast Biopsy
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 UltrasoundGuided Biopsy
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.5 CT guided biopsy
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.6 Others (positron emission mammography (PEM) imaging technology, Xray technology and RX technology)
6.6.1 Market size and forecast
CHAPTER 7 MARKET BY END USERS
7.1 Overview
7.1.1 Market size and forecast
7.2 Diagnostic Centers
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Hospitals
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
CHAPTER 8 MARKET BY GEOGRAPHY
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1 Leica Biosystems (Devicor Medical products, inc.)
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Biopsy Product Portfolio
9.1.4 Strategic moves and developments
9.1.5 SWOT analysis of Leica Biosystems
9.2 Boston Scientific Corporation
9.2.1 Overview
9.2.2 Boston Scientific Corporation snapshot
9.2.3 Operating Business Segment Overview
9.2.4 Business performance
9.2.5 Biopsy Product Portfolio
9.2.6 Strategic moves and developments
9.2.7 SWOT analysis
9.3 Cook Medical, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Biopsy product portfolio
9.3.4 Strategic moves and developments
9.3.5 SWOT analysis of Cook Medical
9.4 Hologic, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Biopsy Product Portfolio
9.4.5 Strategic moves and developments
9.4.6 SWOT analysis of Hologic Inc.
9.5 Mauna kea technologies.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Biopsy product portfolio
9.5.5 Strategic moves and developments
9.5.6 SWOT analysis of Mauna Kea Technologies
9.6 Becton Dickinson and Company (Carefusion Corp.)
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business performance
9.6.4 Biopsy product portfolio
9.6.5 Strategic moves and developments
9.6.6 SWOT analysis of Beckton Dickinson and Company
9.7 C. R. BARD, INC.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Business performance
9.7.4 Biopsy Product Portfolio
9.7.5 SWOT analysis of C.R. Bard, Inc.
9.8 Fujifilm Holdings Corp.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Strategic moves and developments
9.8.5 SWOT analysis of Fujifilm Holdings Corp.
9.9 Veran Medical Technologies
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Biopsy product portfolio
9.9.4 Strategic moves and development
9.9.5 SWOT analysis of Integrated DNA Technologies, Inc.
9.10 Cardinal Health, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Business performance
9.10.4 Biopsy product portfolio
9.10.5 Strategic moves and development
9.10.6 SWOT analysis of Cardinal Health Inc.
List of Figures
FIG. 1 TOP IMPACTING FACTORS, MODERATE GROWTH SCENARIO (20222027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (20222027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (20222027)
FIG. 4 TOP IMPACTING FACTORS (2014-2022)
FIG. 5 TOP WINNING STRATEGIES (20122015)
FIG. 6 KEY PRODUCT LAUNCH (20122015)
FIG. 7 KEY COLLABORATIONS AND PARTNERSHIPSS (20122015)
FIG. 8 PORTERS FIVE FORCE ANALYSIS
FIG. 9 VALUE CHAIN ANALYSIS
FIG. 10 PERCENTAGE OF PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE, AND JAPAN, 20132015
FIG. 11 U.S.: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132015
FIG. 12 EUROPE: PATENT ANALYSIS BY MARKET PARTICIPANT, 20132015
FIG. 13 JAPAN: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132015
FIG. 14 SWOT ANALYSIS OF LEICA BIOSYSTEMS
FIG. 15 REVENUE GENERATED BY BOSTON SCIENTIFIC CORPORATION (20122014)
FIG. 16 NET SALES OF BOSTON SCIENTIFIC CORPORATION, BY GEOGRAPHY (2014)
FIG. 17 NET SALES OF BOSTON SCIENTIFIC CORPORATION. BY PRODUCT GROUPS (2014)
FIG. 18 SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION.
FIG. 19 SWOT ANALYSIS OF COOK MEDICAL
FIG. 20 REVENUE GENERATED BY HOLOGIC INC., (2012-2014)
FIG. 21 SWOT ANALYSIS OF HOLOGIC, INC.
FIG. 22 REVENUE GENERATED BY MAUNA KEA TECHNOLOGIES., (20122014)
FIG. 23 SWOT ANALYSIS OF MAUNA KEA TECHNOLOGIES
FIG. 24 REVENUE GENERATED BY BECKTON DICKINSON AND COMPANY (20122014)
FIG. 25 SWOT ANALYSIS OF BECKTON, DICKISON AND COMPANY
FIG. 26 REVENUE GENERATED BY C.R. BARD INC. (2012-2014)
FIG. 27 SWOT ANALYSIS OF C.R. BARD, INC.
FIG. 28 REVENUE GENERATED BY FUJIFILM HOLDINGS CORP (2012-2014), ($MILLION)
FIG. 29 SWOT ANALYSIS OF FUJIFILM HOLDINGS CORP.
FIG. 30 SWOT ANALYSIS OF INTEGRATED DNA TECHNOLOGIES, INC.
FIG. 31 REVENUE GENERATED BY CARDINAL HEALTH INC. (2012 2014)
FIG. 32 SWOT ANALYSIS OF DNA2.0, INC.
List of Tables
TABLE 1 WORLD BIOPSY DEVICES MARKET, MODERATE GROWTH SCENARIO, BY GEOGRAPHY, 20222025 ($MILLION)
TABLE 2 WORLD BIOPSY DEVICES MARKET RAPID GROWTH SCENARIO, BY GEOGRAPHY, 20222025 ($MILLION)
TABLE 3 WORLD BIOPSY DEVICES MARKET, DIMINISHING GROWTH SCENARIO, BY GEOGRAPHY, 20222025 ($MILLION)
TABLE 4 WORLD BIOPSY DEVICES MARKET, BY TYPE, 2014 2022 ($MILLION)
TABLE 5 WORLD BREAST BIOPSY DEVICES MARKET, BY TYPE, 2014 2022 ($MILLION)
TABLE 6 WORLD BREAST BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 7 WORLD VACCUM ASSISTED BREAST BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 8 WORLD CORE NEEDLE BREAST BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 9 WORLD FINE NEEDLE BREAST BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 10 WORLD GASTROINTESTINAL BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 11 WORLD SOFT TISSUE BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 12 WORLD BRONCHIAL BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 13 WORLD GYNAECOLOGY BIOPSY DEVICES MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 14 WORLD ROBOTIC GUIDANCE SYSTEM DEVICES MARKET, BY GEOGRAPHY,2014 2022 ($MILLION)
TABLE 15 WORLD OTHER DEVICES MARKET BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 16 WORLD BIOPSY DEVICES MARKET, BY APPLICATION, 2014 2022 ($MILLION)
TABLE 17 WORLD BIOPSY DEVICES MARKET, BY NUMBER OF PROCEDURES, 2014 2022 ($MILLION)
TABLE 18 WORLD BREAST BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 19 WORLD GASTROENTEROLOGY BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 20 WORLD PROSTATE BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 21 WORLD LIVER BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 22 WORLD LUNG BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 23 WORLD KIDNEY BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 24 WORLD GYNAECOLOGY BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 25 WORLD OTHER BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 26 WORLD BIOPSY DEVICE MARKET, BY IMAGE GUIDED TECHNOLOGY, 2014 2022 ($MILLION)
TABLE 27 WORLD MRI-GUIDED BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 28 WORLD STEREOTACTIC-GUIDED BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 29 WORLD ULTRASOUND-GUIDED BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 30 WORLD CT-GUIDED BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 31 WORLD OTHER IMAGE GUIDED BIOPSY MARKET, BY GEOGRAPHY, 2014 2022 ($MILLION)
TABLE 32 WORLD BIOPSY DEVICES MARKET, BY END USERS, 2014 2022 ($MILLION)
TABLE 33 WORLD BIOPSY DEVICES MARKET, DIAGNOSTIC CENTERS, 2014 2022, ($MILLION)
TABLE 34 WORLD BIOPSY DEVICES MARKET, BY HOSPITALS, 2014 2022, ($MILLION)
TABLE 35 WORLD BIOPSY DEVICE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 36 NORTH AMERICA BIOPSY DEVICE MARKET, BY DEVICE TYPE, 20142022 ($MILLION)
TABLE 37 EUROPE BIOPSY DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 38 ASIA-PACIFIC BIOPSY DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 39 LAMEA BIOPSY DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 40 LEICA BIOSYSTEMS SNAPSHOT
TABLE 41 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
TABLE 42 BOSTON SCIENTIFIC CORPORATION OPERATING SEGEMENTS
TABLE 43 COOK MEDICAL SNAPSHOT
TABLE 44 HOLOGIC INC., SNAPSHOT
TABLE 45 MAUNA KEA TECHNOLOGIES SNAPSHOT
TABLE 46 COMPANY SNAPSHOT OF BECTON DICKINSON AND COMPANY
TABLE 47 COMPANY SNAPSHOT
TABLE 48 FUJIFILM HOLDINGS CORP., SNAPSHOT
TABLE 49 COMPANY SNAPSHOT OF INTEGRATED DNA TECHNOLOGIES, INC
TABLE 50 COMPANY SNAPSHOT OF DNA2.0, INC.
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
